Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Tokyo - Delayed Quote JPY

DVx Inc. (3079.T)

916.00
+18.00
+(2.00%)
At close: April 28 at 3:30:00 PM GMT+9

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in JPY.
NameTitlePayExercisedYear Born
Mr. Hiroshi Shibasaki President, CEO & Director -- -- 1965
Mr. Satoshi Miyamoto Executive Officer & Director -- -- 1959
Hideki Nakai Executive Officer -- -- --
Takeshi Hatano Executive Officer, GM of Central Japan Third Sales Department & Director -- -- 1977
Takeshi Nagata Executive Officer -- -- --
Satoshi Suwa Executive Officer & Director -- -- 1974
Yusai Furukawa Executive Officer -- -- --
Mr. Takeshi Takada Executive Officer -- -- --
Masaru Kasono Vascular Sales Department Manager & Executive Officer -- -- --
Tatsuya Kimura Executive Officer -- -- --

DVx Inc.

Mejiro Nakano Building
5th Floor 2-17-22 Takada Toshima-ku
Tokyo, 171-0033
Japan
81 3 5985 6123 https://www.dvx.jp
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
316

Description

DVx Inc. engages in the research and development, design, purchasing/selling, import/export, repair, maintenance and inspection, and rental of medical devices and related peripheral devices in Japan. The company offers arrhythmia-related products, such as cardiac pacemakers, implantable cardioverter defibrillators, electrode catheters, and ablation catheters; ischemia-related products, that includes RAQUOS and resolution/resolution SD; and EPS Trainer, an intracardiac electrograms simulator; and wonder belt products. The company also engages in the design, manufacture, and purchasing/selling of medical computers; manufacture, purchasing/selling, repair, maintenance and inspection, rental, leasing, and import/export of medicines, quasi drugs, cosmetics, health foods, daily goods, nursing care products, and nursing care equipment; provision of internal and external medical and medical device-related general consulting and services, as well as medical publishing and market research services; and sale and purchase of second hand goods. DVx Inc. was incorporated in 1986 and is headquartered in Tokyo, Japan.

Corporate Governance

DVx Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 15, 2025 at 6:00 AM UTC

DVx Inc. Earnings Date

Recent Events

March 28, 2025 at 12:00 AM UTC

Ex-Dividend Date